Immunohistochemical expression of multidrug resistance proteins in mature T/NK-cell lymphomas

$48.00 plus tax (Refund Policy)

Download / Buy Article:

Abstract:

Saglam A, Hayran M, Uner AH, Immunohistochemical expression of multidrug resistance proteins in mature T/NK-cell lymphomas. APMIS 2008;116:791–800.

Multidrug resistance (MDR) is defined as resistance of tumor cells to a wide spectrum of structurally and functionally unrelated drugs. One of the most important mechanisms in mediating MDR is that involving cellular drug efflux transporters. Drug resistance is a common and formidable obstacle to therapy in mature T/NK-cell lymphomas and the MDR phenotype is thought to be one of the contributing mechanisms. In this study we assessed the immunohistochemical expression of P-gp (P-glycoprotein), MRP-1 (multidrug resistance associated protein 1), BCRP (breast cancer resistance protein) and LRP (lung resistance protein) in 45 mature T/NK-cell lymphomas diagnosed at our hospital. We detected P-gp expression in 31% (13/42), MRP-1 expression in 74% (31/42), BCRP in 78% (32/ 41) and LRP in 59% (26/44) of the cases. These findings show that our T/NK-cell lymphoma cases display high frequency of MDR protein expression.

Keywords: P-glycoprotein; T-cell lymphoma; breast cancer resistance protein; lung resistance protein; multidrug resistance associated protein

Document Type: Original Article

DOI: http://dx.doi.org/10.1111/j.1600-0463.2008.00974.x

Affiliations: 1: Pathology 2: Preventive Oncology, Oncology Institute, Hacettepe University Faculty of Medicine, Ankara,Turkey

Publication date: September 1, 2008

Related content

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more